Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPV and NA-831 for COVID-19 Prevention and Treatment
NCT04540185Phase 3Unknown
- Sponsor
- Biomed Industries
- Start
- Nov 2020
- Primary completion
- Nov 2022
- Modality
- Live Attenuated Vaccines, Small Molecules, Whole Inactivated Vaccines
- Countries
- 2
01
Overview
A Phase 3 trial of poliovirus vaccine, cyclo(prolylglycyl) in coronavirus disease 2019 (COVID-19), sponsored by Biomed Industries. Status: unknown.
02
Drugs
poliovirus vaccinecyclo(prolylglycyl)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04540185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04540185.